Wet AMD and DME Drug Development Summit | Virtual Event | April 13-15, 2021
Evvnt Promotion / evvnt
13.04.2021 - 15.04.2021 Online
Time: 08:00 - 15:45
Conference themes
The Wet AMD and DME Drug Development Summit comes at a critical juncture, as the research community progresses novel drug candidates targeting angiogenesis-driven disease, and a pandemic further exposes the treatment limitations for a global aging population.
The treatment landscape for Wet Age-Related Macular Degeneration (wet AMD) and Diabetic Macular Edema (DME) has dramatically changed since the first anti-VEGF therapies were approved for ocular neovascularization.
The Wet AMD and DME Drug Development Summit comes at a critical juncture, as the research community progresses novel drug candidates targeting angiogenesis-driven disease, and a pandemic further exposes the treatment limitations for a global aging population.
The treatment landscape for Wet Age-Related Macular Degeneration (wet AMD) and Diabetic Macular Edema (DME) has dramatically changed since the first anti-VEGF therapies were approved for ocular neovascularization.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
Brochure: https://go.evvnt.com/722199-2?pid=4832
Speakers: Casey Kopczynski, Chief Scientific Officer, Aerie Pharmaceuticals, Kevin Peters, Chief Scientific and Medical Officer and Senior Vice President, Aerpio Therapeutics and more.
Brochure: https://go.evvnt.com/722199-2?pid=4832
Speakers: Casey Kopczynski, Chief Scientific Officer, Aerie Pharmaceuticals, Kevin Peters, Chief Scientific and Medical Officer and Senior Vice President, Aerpio Therapeutics and more.
Enquiries and Registration:
https://go.evvnt.com/722199-0?pid=4832
Ms. Stephanie Nketia
General Medicine
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
